News 2017-12-15T10:33:30+00:00

For more information on C3HealthcareRx or to arrange an interview with a company representative, please contact:

Todd Shoe, Chief Growth Officer

tshoe@c3healthcarerx.com

(919) 341-3845

C3HealthcareRx Announces Series A Funding, Multistate Expansion and New Headquarters

Unique service provides “pharmacy home” for patients with chronic and complex medical conditions

October 2, 2017 (Raleigh, NC) – C3HealthcareRx (“C3“), which partners with health plans and health systems to provide in-home medication management and a “pharmacy home” for patients with chronic and complex medical conditions, announced today that it has secured $7.2 million in Series A private investment funding to continue to fuel its growth. The company simultaneously announced that it will be moving into new headquarters in Morrisville, N.C. in October, and that it has signed new clients in North Carolina and California and expanded its relationship with a large national health plan.

“Our target patients typically average five to seven chronic maintenance medications and are dealing with complex dosing regimens as well as social challenges every day,” said C3 CEO Susan Weaver, MD, FACP. “We bring pharmacy specialists to them with a high-touch approach that simplifies how they manage their medications.

“By engaging patients in their homes, helping them better understand and adhere to their prescribed medications, and serving as an extension of the healthcare team, we’re accomplishing the ‘triple aim’ of healthcare–improving the patient experience, improving the health of distinct patient populations, and reducing the per-capita cost of health care. That’s what really excites our clients, and it’s been the driving force behind our growth,” Weaver said.

In the C3 model, the patient is visited at home by a C3 certified pharmacy technician (CPhT) who completes a full medication inventory and health assessment and then facilitates an in-person or “virtual” counseling session with a C3 pharmacist. The pharmacist checks for medication errors, missing medications, potential drug-drug interactions and duplications of therapies, and then works directly with the patient’s physician(s) to make any necessary changes and to recommend lower-cost alternatives when appropriate. The C3 pharmacist also discusses medication concerns with the patient and provides medication counseling.

Weaver said that the company’s innovative approach has delivered quantifiable, sustainable results for its clients, including:

  • Hospital readmission rates that average 30 percent lower than baseline readmission rates at C3 client hospitals and health systems;
  • Medication adherence rates that are consistently in 5 Star range for Medicare Advantage patients with hypertension, high cholesterol and diabetes;
  • Utilization of lower-cost medication regimens in more than 51 percent of cases managed by C3; and
  • Identification and correction of potential errors in 42 percent of all patient visits.

“With an increasing focus on value based healthcare, payers are linking reimbursement to results. They want to pay for ‘an outcome,’ not ‘an activity,’ and that bodes well for us at C3,” Weaver said. “This new Series A funding will let us broaden our reach to serve more patients, plans and health systems in both existing and new markets.”

C3 was founded in 2013. Today, the company has more than 60 employees and serves clients in 11 states: North Carolina, Virginia, and California (pharmacy locations) as well as Florida, Ohio, Kentucky, Georgia, New York, Pennsylvania, Connecticut and Rhode Island.

To accommodate its recent growth, C3 will move into new space in the Southport Business Park in Morrisville, N.C in October.  The location will house a new pharmacy and the company’s headquarters including a senior management team that recently added two industry veterans: Todd Shoe is the company’s first-ever Chief Growth Officer and Brad Marshburn, Pharm.D. joined the team as the company’s VP of pharmacy operations.

“I’m thrilled about this team and our future. We’ve got the right people in place, and we’re offering the right combination of ‘high-touch and high-tech’ services that drive verifiable outcomes,” said Board Chair, Ned Jannotta. “Our home visits paint a unique picture of our complex patients, and our suite of technologies allows us to deliver high-touch solutions affordably.”

Weaver added that she believes C3 has found success by benefiting multiple stakeholders at the same time.

“Patients like our personal attention and service, providers like seeing their patients improve their health and avoid ER visits and hospital readmissions, and payers like being able to reduce unnecessary expenses,” she said. “It’s a rare ‘win-win-win’ for healthcare.”

About C3HealthcareRx

Headquartered in Raleigh, NC, C3HealthcareRx works with health plans and health systems to provide a “pharmacy home” for patients with chronic and complex conditions. Its three “Cs” stand for “care,” “collaboration,” and “compliance,” and it leverages those key attributes to help clients improve health outcomes and generate savings through innovative in-home medication management and personalized pharmacy services. It operates pharmacies in Richmond, Va., Los Angeles, Calif., and Raleigh, N.C., and serves patients in Florida, Kentucky, North Carolina, Ohio, Georgia, Virginia, California, New York, Pennsylvania, Rhode Island and Connecticut.

# # #

C3HealthcareRx Adds Todd Shoe as Chief Growth Officer

September 5, 2017 (Raleigh, NC) – C3HealthcareRx announced today that it has added Todd Shoe to its executive management team as Chief Growth Officer.

“Todd is a perfect fit for us as we continue to expand in our current footprint and introduce C3 to new markets,” said Susan Weaver, MD, FACP, CEO of C3. “His extensive track record in healthcare—most notably his experience working with national health plans—ideally positions him to help us match ‘message with market’ even better than before. Todd has a clear understanding of the hurdles our clients are facing and how our solutions help them clear those hurdles in smart, cost-efficient ways. We’re confident he’ll help us grow our pipeline and maximize the effectiveness of all C3 marketing and sales initiatives.”

Shoe was most recently the Executive Vice President of Sales & Marketing at Houston, TX-based HealthHelp, a specialty benefits management company. He has also held executive sales and marketing positions at CVS Caremark, among other organizations. Shoe has been recognized for excellence in new business development at multiple employers, including being honored as an Achievement Award Winner at Bristol-Myers Squibb, President’s Award Winner at Kayser-Roth Corporation and Presidents Award Winner at CVS Caremark.

He holds a Bachelor of Arts in Business Administration from the University of North Carolina at Charlotte.

Susan T. Weaver, MD, FACP, to Lead C3HealthcareRx as New CEO

July 5, 2016 (Raleigh, NC) – C3HealthcareRx, a medication management and pharmacy services innovator, announced today that Susan T. Weaver, MD, FACP, has joined the company as its Chief Executive Officer (CEO). Dr. Weaver served most recently as the founder and President of Transformation Health Partners, LLC, and as Chief Medical Officer at Blue Cross and Blue Shield of North Carolina (BCBSNC), the state’s largest health insurer. As CEO of C3, she will be responsible for the company’s strategic vision, day-to-day operations and key national business relationships.

“We’re both honored and excited that Susan accepted our offer to lead C3 as we transition from a regional to a national organization,” said C3 founder and former CEO Michael Perriccio, who moves into a new role as President of C3. “When I began the search and started vetting candidates, Susan quickly rose to the top of the list. She’s a respected clinical professional and has served as a senior executive in both the healthcare system and payor space. She brings a unique combination of experience and credibility to our organization since she understands the world of our patients as well as our provider and payor partners.”

Perriccio said that the timing of Weaver’s appointment is ideal for C3 as it continues to expand its programs of medication-management and transitional-care services–and expands its footprint beyond the company’s roots in the mid-Atlantic region.

“Randomly scan the headlines in any healthcare trade publication, and you’re almost guaranteed to see the term ‘value-based care’ emphasized. It’s no surprise that that’s where everything is headed,” Perriccio said. “Susan understands what value-based care really means for everyone involved in the system, so she’ll help us stay focused on adding value as we grow.”

Weaver said that C3 has the opportunity to be a pacesetter at a time when the industry is eagerly seeking processes that deliver quantifiable results.

“Our core programs for medication management and transitional care are well developed. We have empirical data and proven outcomes,” she said. “Now it’s really about scale. It’s about becoming a trusted resource nationally for providers, health systems, payors and individual consumers.”

Weaver added the opportunity to advance consumer-driven healthcare through C3 provided a strong attraction to joining the company.

“The programs at C3 provide rare ‘win-win-win’ partnership opportunities across the healthcare continuum. Our programs are beneficial to patients because we simplify how they manage their medications. C3 programs enable physicians to deliver better quality care without additional administrative burdens. Accountable care organizations and health plans love our programs because we partner with them to reduce the costs of healthcare delivery while delivering high quality care and a superior member experience.”

Prior to joining BCBSNC, Weaver held various executive positions at WakeMed Health & Hospital (Raleigh, NC), including serving as the organization’s Executive Vice President of Medical Affairs and Physician Practices. She was a founding member and Executive Director of Alliance Medical Ministry, a not-for-profit organization providing medical care to the working uninsured of Wake County, NC. Weaver earned a M.D. from the Duke University School of Medicine (Durham, NC) and B.S. in Psychology from Duke University, and completed postgraduate training at Massachusetts General Hospital (Boston, MA). She is board-certified in Internal Medicine and is a Fellow of the American College of Physicians.

Readmission Reduction Pilot Launched by CentraHealth, C3HealthcareRx

November 16 , 2015 (Lynchburg, Va.) – Through an initial pilot program that begins in January, Centra Lynchburg General Hospital and C3HealthcareRx will analyze how patients cared for through the C3 Readmissions Reduction Program compare with similar patient populations discharged from the hospital who are not participating in the C3 program. The initiative marks the tenth such hospital readmission reduction program initiated by C3 in the company’s brief history.

Through the pilot, a C3 pharmacist will provide onsite medication reconciliation and discharge medication counseling services to select Centra patients prior to discharge from Centra Lynchburg General Hospital. For a 30-day post-discharge period, patients participating in the pilot will receive three in-home follow-up medication management visits from a C3 certified pharmacy technician (CPhT), in addition to free home delivery of their medications (if they choose to receive that service).

Centra is regional health system that manages two hospitals, Lynchburg General Hospital (in Lynchburg, Va.) and Southside Community Hospital (in Farmville, Va.). Lynchburg General Hospital has been recognized by Thomson Reuters as one of the nation’s 50 Top Cardiovascular Hospitals.

C3HealthcareRx Contributes to Regional Healthcare Philanthropy Efforts

November 30, 2015 (Richmond, Va. and Raleigh, NC) – C3HealthcareRx took to the course—and to the street—to support recent fundraisers by the American Heart Association’s Greater Richmond Chapter.

C3 sponsored a hole at the AHA Richmond golf tournament (Oct. 8, 2015) and the company’s CEO, Michael Perriccio, played in the tourney. C3 also supported the AHA’s annual Heart Walk in Richmond (Oct. 11, 2015) by sponsoring a route sign.

In Raleigh, C3 was proud to be a table supporter for the Cystic Fibrosis Association’s recent Brewers Ball (Nov. 20, 2015), hosted by the organization’s Carolinas Chapter. Event participants were treated to beers from some of the region’s best craft breweries and food from some of its hottest restaurants, and were encouraged to bid on silent auction items.

C3HealthcareRx Exhibits and Sponsors Regional Case Management, Health System Conferences

November 16, 2015 (Columbia, SC, Concord, NC and Hot Springs, Va.) – Attendees at three recent Southeastern US regional healthcare association meetings were introduced to the unique model for medication management and transitional care services initiated by C3HealthcareRx.

The American Case Management Association – North Carolina Chapter (Concord, NC; Sept. 18, 2015) and the American Case Management Association – South Carolina Chapter (Columbia, SC; Oct. 29-30, 2015) brought together Case Management leaders from hospitals, health systems and payors from across the region.

C3 was also an event sponsor for the Virginia Hospital and Healthcare Association Annual Meeting in Hot Springs, Virginia (Nov. 11-13, 2015), which was attended by more than 300 professionals representing executive leadership and board members of hospitals and health systems throughout Virginia.

Readmission Reduction Pilot Launched by CentraHealth, C3HealthcareRx

November 16 , 2015 (Lynchburg, Va.) – Through an initial pilot program that begins in January, Centra Lynchburg General Hospital and C3HealthcareRx will analyze how patients cared for through the C3 Readmissions Reduction Program compare with similar patient populations discharged from the hospital who are not participating in the C3 program. The initiative marks the tenth such hospital readmission reduction program initiated by C3 in the company’s brief history.

Through the pilot, a C3 pharmacist will provide onsite medication reconciliation and discharge medication counseling services to select Centra patients prior to discharge from Centra Lynchburg General Hospital. For a 30-day post-discharge period, patients participating in the pilot will receive three in-home follow-up medication management visits from a C3 certified pharmacy technician (CPhT), in addition to free home delivery of their medications (if they choose to receive that service).

Centra is regional health system that manages two hospitals, Lynchburg General Hospital (in Lynchburg, Va.) and Southside Community Hospital (in Farmville, Va.). Lynchburg General Hospital has been recognized by Thomson Reuters as one of the nation’s 50 Top Cardiovascular Hospitals.

C3HealthcareRx Acquires Raleigh, NC-Based Paired Health

July 6, 2015 (Raleigh, NC) – Through a transaction completed on June 30, 2015, two similarly inspired regional companies—Raleigh, NC-based C3HealthcareRx and Raleigh, NC-based Paired Health—are joining forces to enhance medication management and transitional care services offered by hospitals and health systems to their patients.

“Independently, we’ve each been approaching a common problem—reducing hospital readmissions and improving health outcomes for high-risk patient populations—from slightly different perspectives,” said C3 CEO Michael Perriccio. “But together, we’ll be able to capitalize on our combined strengths and experiences. We each have a proven track record with our respective clients and their patients, so now we’re integrating processes and technologies that are primed to drive even more value from readmission reduction and medication management efforts.”

The combined organization will operate under the C3 banner. In simplest terms, its core offerings will feature medication reconciliation, medication education, in-home post acute visits, and long-term medication management.

“To make a real, lasting dent in the rate of readmissions, you have to address multiple issues simultaneously. And you have to do it with efficiency and value top-of-mind,” said Sean Harrison, who was the CEO of Paired Health and who now serves as the Chief Operating Officer (COO) of C3. “By joining forces, we can deliver four critical services—medication reconciliation, medication education, in-home post-acute visits, and pharmacy services—in a way that can help our clients make a measurable, repeatable impact in reducing readmissions.”

Paired Health’s programs with WakeMed (Raleigh, NC) and Wake Forest Baptist Health (Winston-Salem, NC), help expand the C3 footprint into North Carolina as patients enrolled in these programs will have the option of becoming patients of the C3 pharmacy, which promotes better long-term medication management through synchronized medication refills, monthly care calls and free prescription deliveries.

Bon Secours Our Lady Bellefonte Hospital Teams with C3HealthcareRx to Reduce Readmissions

July 17, 2015 (Ashland, KY) – Raleigh, NC-based C3HealthcareRx reached an important corporate milestone today, initiating its first readmission reduction partnership with a hospital outside of Virginia, which is home to the company’s pharmacy and one of its four regional offices. Ashland, KY-based Bon Secours Our Lady Bellefonte Hospital and C3 have set a joint goal to reduce readmissions to the hospital among high-risk patients by 20%.

The program will begin on October 8, 2015, and will feature discharge medication reconciliation and medication counseling by a C3 pharmacist on-site at the hospitalnd in-home follow-up visits conducted by a C3 certified pharmacy technician (CPhT). Our Lady Bellefonte is part of the Bon Secours Health System (headquartered in Marriottsville, MD), which owns, manages, or joint ventures 19 acute-care hospitals across six states.

In-Home Post-Discharge Visits Improve Quality Measures for Holston Medical Group ACO Patients

March 31, 2015 (Kingsport, TN) – In just six weeks’ time, an initiative designed to reduce readmissions and enhance wellness among recently-discharged hospital patients has produced favorable results for Kingston, TN-based Holston Medical Group (HMG).

The initiative, managed by Raleigh, NC-based C3HealthcareRx, saw 465 HMG patients visited in their homes by a C3 certified pharmacy technician (CPhT). C3 team members conducted both medication reconciliation and Annual Medicare Wellness Assessments for patients assigned to the program. The end result was a 15% increase in HMG’s quality measure scores — up to 87% from 73% — during the first six weeks of the program.

HMG is part of Qualuable ACO, which promotes collaboration among healthcare providers throughout Northeast Tennessee and Southwest Virginia and is regarded as one of the nation’s top-performing accountable care organizations (ACOs).

Chesapeake Regional Medical Center and C3HealthcareRx partner to Improve Medication List Accuracy and Medication Management after Discharge

March 18, 2015 (Chesapeake, Va.) — Chesapeake Regional Medical Center has entered into a partnership with C3HealthcareRx and will implement C3’s Admission Medication Reconciliation Service, in addition to C³’s Discharge Medication Counseling and In-Home Medication Management Services.

The goal of the program is to ensure that CRMC has an accurate medication list for all of its medically complex patients, in addition to helping those patients manage their complex medication regimens after they are discharged from the hospital.

The program, slated to begin in early-June, will include a C3 Certified Pharmacy Technician (CPhT) staffed in the CRMC Emergency Department 12 hours a day. During that time, the CPhT will be responsible for gathering accurate home medication lists on all high-risk patients admitted to CRMC through the ED.

Upon discharge, these patients will also be counseled on their medications by a C3 pharmacist and then visited in the home by a CPhT within 48 hours of discharge from the hospital. The purpose of the home visit is to ensure that the patients have the correct medications and know how to take them properly.

The CPhT will visit each patient a total of three times during the critical 30 days following discharge from the hospital, reviewing their medications and ensuring medication compliance during each home visit.

Bon Secours Virginia Signs on C3 to Reduce Readmissions at Two More Virginia Hospitals

February 13. 2015 (Norfolk, Va.) — C3HealthcareRx has signed contracts with two more Bon Secours Virginia hospitals, and will roll out its Medication Management and Readmission Reduction Program to Memorial Regional Medical Center in Mechanicsville, Virginia, and DePaul Medical Center in Norfolk, Virginia.

The expanded partnership is a result of the success of the C3 program at Bon Secours Richmond Community Hospital, where the C3 program readmission rate has held steady at just 4% for more than a year.

When asked about being the first Bon Secours hospital to work with C3, Chief Medical Officer Dr. Yvette Johnson-Threat said “The partnership has been wonderful, and I am proud that we have been able to be the pilot site for Bon Secours . . . the C3 staff have integrated with our staff very well and are seen as an extension of Bon Secours staff. This relationship means that patients understand that C3 is part of the treatment team. The communication that they have with our case managers and providers only reinforces the concept.”

The program at Memorial Regional Medical Center is set to begin at the end of February, and the DePaul Medical Center program will start at the end of March.

UVA Culpeper Hospital, C3HealthcareRx Partner to Reduce Readmissions

November 10, 2014 (Culpeper, Va.) — C3HealthcareRx is joining forces with UVA Culpeper Hospital to reduce readmissions and improve health outcomes for the hospital’s patients.

The program, set begin in December, features a C3 pharmacist onsite at UVA Culpeper Hospital providing Medication Reconciliation and Discharge Medication Counseling services to patients. After these patients are discharged from the hospital, they will receive three in-home medication management appointments during the next 30 days, in addition to free home delivery of their medications, if desired.

When asked about the partnership, C3 CEO Mike Perriccio stated, “We are excited about the opportunity to partner with such a reputable hospital to help improve the quality of life for the region’s patients. By working together, we can truly impact lives and improve these patients’ overall health.”

Tri-Cities Readmission Program Brings Holston Medical Group, C3HealthcareRx Together

October 24, 2014 (Kingsport, TN) — C3HealthcareRx is partnering with Holston Medical Group, one of the most respected physician-led, multi-specialty groups in the southeastern United States, to provide In-Home Medication Management Services to patients in the Tri-Cities area.

HMG and C3 teammates will collaborate to perform patient outreach, in-home medication management services, and in-home health assessments with more than 1,000 of HMG’s patients by the end of 2014.

The goal of the partnership is to help HMG’s patients understand how to take their medications correctly, and to verify the medications that each patient has in his or her home. C3 will also assist HMG in ensuring that each patient’s profile has up-to-date health history information, as well as providing patients with in-home flu shots and pneumonia vaccines.

C3HealthcareRx “R2” Program Produces Remarkable Results for Bon Secours Richmond Community Hospital

March 4, 2014 (Richmond, Va.) — The first 90 days of the C3HealthcareRx Readmission Reduction “R2” Pilot Program have produced remarkable results at Bon Secours Richmond Community Hospital, allowing the program to be extend beyond the 90-day pilot period and into a long-term program.

When the C3 program began, Richmond Community Hospital had a baseline readmission rate of 11%, and just three months into the program the rate dropped to around a 3.2%.

“The results with this very difficult patient population have been remarkable,” said Dr. Yvette Johnson-Threat, CMO at Bon Secours Richmond Community Hospital.

Dr Johnson-Threat further stated, “The C3 staff have integrated with our staff very well. They are seen as an extension of Bon Secours staff. This relationship means that patients understand that C3 is part of the treatment team. The communication that they have with our case managers and providers only reinforces the concept.”